Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients

Sticking to It: Improving Outcomes by Increasing Adherence

(2016) Dawn L. Hershman   JOURNAL OF CLINICAL ONCOLOGY

Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis

(2016) Johanna Holm et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk Factors and Tumor Characteristics of Interval Cancers by Mammographic Density

(2015) Johanna Holm et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer

(2015) Wei He et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of Fertility Concerns on Tamoxifen Initiation and Persistence

(2015) Natalia C. Llarena et al.   JNCI-Journal of the National Cancer Institute

Impact of Fertility Concerns on Tamoxifen Initiation and Persistence

(2015) Natalia C. Llarena et al.   JNCI-Journal of the National Cancer Institute

Risk-Benefit Profiles of Women Using Tamoxifen for Chemoprevention

(2014) Hazel B. Nichols et al.   JNCI-Journal of the National Cancer Institute

The Change From Brand-Name to Generic Aromatase Inhibitors and Hormone Therapy Adherence for Early-Stage Breast Cancer

(2014) Dawn L. Hershman et al.   JNCI-Journal of the National Cancer Institute

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

(2013) B Makubate et al.   BRITISH JOURNAL OF CANCER

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study

(2012) Annette Wigertz et al.   BREAST CANCER RESEARCH AND TREATMENT

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

(2012) Caitlin C. Murphy et al.   BREAST CANCER RESEARCH AND TREATMENT

Cure Models as a Useful Statistical Tool for Analyzing Survival

(2012) M. Othus et al.   CLINICAL CANCER RESEARCH

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

(2012) N. Lynn Henry et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time

(2011) C. Cluze et al.   ANNALS OF ONCOLOGY

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer

(2011) Alfred I. Neugut et al.   JOURNAL OF CLINICAL ONCOLOGY

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

(2010) Dawn L. Hershman et al.   BREAST CANCER RESEARCH AND TREATMENT

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis

(2010) Myrthe P. P. van Herk-Sukel et al.   BREAST CANCER RESEARCH AND TREATMENT

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

(2010) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Adherence with adjuvant hormonal therapy for breast cancer

(2009) K. J. Ruddy et al.   ANNALS OF ONCOLOGY

The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

(2009) Jonas F. Ludvigsson et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

The completeness of the Swedish Cancer Register – a sample survey for year 1998

(2008) Lotti Barlow et al.   ACTA ONCOLOGICA

Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer

(2007) Cynthia Owusu et al.   JOURNAL OF CLINICAL ONCOLOGY